Soluble adhesion molecules in Behçet's disease

References

• Mizuki N, Ohno S, Nakamura S. Possible effects of genes in the HLA region on susceptibility to Behçet's disease. Chibret Int J Ophthalmol 1992;9(2):I0–21.
   Google Scholar
• Nakae K, Masaki F, Hashimoto T. A nation-wide epidemiological survey on Behçet's disease, report 2: association of HLA B51 with clinical-epidemiological features. Report of Behçet's Disease Research Committee, Japan, Ministry of Health and Welfare, 1992; 70–82.
   Google Scholar
• Howe L, Denman A, Dinning W, Graham E, Lightman S, Towler H. Visual prognosis in Behçet's disease. In: Godeau P, Wechsler B, editors. Behçet's Disease. Amster-dam: Elsevier Science Publishers, 1993; 599–602.
   Google Scholar
• Gill A, Esin S, Dilsen N, Koniçe M, Wigzell H, Biberfeld P. Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol 1995;132:901–907.
   Google Scholar
• Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13(3):106–112.
   PubMedGoogle Scholar
• Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity 1992;12(3):201–206.
   PubMed Web of Science ®Google Scholar
• Essin S, Gill A, Hodara V, Jeddi-Tehrani M, Dilsen N, Konice M, Anderrson R, Wigzell H. Peripheral blood T cell expansions in patients with Behçet's disease. Clin Exp Immunol 1997;107:520–527.
   Google Scholar
• Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38(3)426–433.
   Google Scholar
• Hayasaka S, Kawamoto K, Noda S, Kodama T. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporine. Ophthalmologica 1994;208:210–213.
   PubMed Web of Science ®Google Scholar
• Seth R, Raymond FD, Makgoba MW. Circulating ICAM-I isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338(8759):83–84.
   Google Scholar
• Pigott R, Dillon LP, Hemingway TB, Gearing AJH. Soluble forms of E-selectin, ICAM-I and VCAM-I are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;I87(2):584–589.
   Google Scholar
• Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-I in human serum. J Immunol 1991;147:3788–3793.
   PubMed Web of Science ®Google Scholar
• Baumer I, Zissel G, Schlaak M, Muller-Quernheim J. Shed soluble ICAM-I molecules in bronchoalve-olar lavage cell supernatants and serum of patients with pulmonary sarcoidosis. Lung 1997;175(2):1o5-116.
   Google Scholar
• Janssen BA, Luqmani RA, Gordon C, Hemigway IH, Bacon PA, Gearing AJ, Emery P. Correlation of blood levels of soluble vascular cell adhesion molecule-, with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994;33(12):1112–1 I 16.
   Google Scholar
• Zaman AG, Edelsten C, Stanford MR, Graham EM, Ellis BA, Direskeneli H, D'Cruz DP, Hughes GRV, Dumonde DC, Wallace GR. Soluble intercellular adhesion molecule-, (sICAM-I) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol 1994;95:60–65.
   Google Scholar
• Palmer HE, Zaman AG, Ellis BA, Stanford MR, Graham EM, Wallace GR. Longitudinal analysis of soluble intercellular adhesion molecule i in retinal vasculitis patients. Eur J Clin Invest 1996;26:686–691.
   PubMed Web of Science ®Google Scholar
• Aydintug AO, Tokgoz G, Ozoran K, Duzgun N, Gurler A, Tutkak H. Elevated levels of soluble intercellular adhesion molecule-, correlate with disease activity in Behçet's disease. Rheumatol Int 1995;15(2):75–78.
   PubMed Web of Science ®Google Scholar
• Cronstein BN, Weissmann G. The adhesion molecules of inflamma-tion. Arthritis Rheum 1993;36:147–157.
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Huber PJ. Robust estimation of a location parameter. Ann Math Stat 1964;35:73–101.
   Google Scholar
• Whitcup SM, DeBarge LR, Caspi RR, Harming R, Nussenblatt RB, Chan CC. Monoclonal antibodies against ICAM-I (CD 54) and LFA-I (CD, a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol 1993;67(2):143–150.
   PubMedGoogle Scholar
• Uchio E, Kijima M, Tanaka S, Ohno S. Suppression of experimental uveitis with monoclonal antibodies to ICAM-I and LFA-I. Invest Ophthalmol Vis Sci I994;35(5):2626–2631.
   Google Scholar
• Wakefield D, McCluskey P, Palladinetti P. Distribution of lymphocytes and cell adhesion molecules in iris biopsy specimens from patients with uveitis. Arch Ophthalmol 1992;110:121–125.
   Google Scholar
• Whitcup S, Chan CC, Li Q, Nussenblatt R. Expression of cell adhesion molecules in posterior uveitis. Arch Ophthalmol 1992;I 10:662–666.
   Google Scholar
• George RK, Chan C, Whitcup SM, Nussenblatt RB. Ocular immunopathology of Behçet's disease. Surv Ophthalmol 1997;42(2):157–162.
   PubMed Web of Science ®Google Scholar
• Arocker-Mettinger E, Steurer-Georgiew L, Steurer M, Huber-Spitzy V, Hoelzl E, Grabner G, Kucher A. Circulating ICAM-I levels in serum of uveitis patients. CUIT Eye Res 1992;ii(Suppl.):161–166.
   Google Scholar
• Liversidge J, Sewell HF, Forrester JV. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology I990;71:39o–396.
   Google Scholar
• Simpson KJ, Jones AL, Forbes Howie A, Hayes PC. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis. Eur J Gastroenterol Hepatol 1995;7(5)455–460.
   Google Scholar
• Macchioni P, Boiardi L, Meliconi R, Salvarani C, Grazia Uguccioni M, Rossi F, Pulsatelli L, Facchini A. Elevated soluble intercellular adhesion molecule I in the serum of patients with polymyalgia rheumatica: influence of steroid treatment. J Rheumatol 1994;21(H):186o–1864.
   Google Scholar
• Tailor A, Das AM, Getting SJ, Flower RJ, Perretti M. Subacute treatment of rats with dexametha-sone reduces ICAM-I levels on circulating monocytes. Biochem Biophys Res Commun 1997;231 (3):675–678.
   Google Scholar
• Palmer HE, Zaman AG, Edelsten CE, Stanford MR, Graham EM. Systemic morbidity in patients with isolated idiopathic retinal vasculitis. Lancet 1995;346(8973):505–506.
   Google Scholar
• Gul A, Ozbeck U, Ozturk C, Inanc M, Konice M, Ozcelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 1996;35:1178–1180.
   PubMedGoogle Scholar
• Wakefield TW, Strider RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield U. Venous thrombosis-associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules. Venous Thromb Inflamm 1995;15(2):258–268.
   Google Scholar
• Blann AD, Herrick A, Jayson MIV. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheum 1995;34:814–819.
   Google Scholar
• Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-I, ICAM-3, VCAM-I, E-selectin, L-selectin, and P-selectin) in rheumatoid arthritis. Br J Rheum 1997;36:164–169.
   PubMedGoogle Scholar
• Nageneni N, Kutty RK, Detrick B, Hooks JJ. Inflammatory cytokines induce intercellular adhesion molecule-1 (ICAM-I) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures. Cytokine 1996;8:622–630.
   PubMed Web of Science ®Google Scholar
• Franks WA, Limb GA, Stanford MR, Ogilvie J, Wolstencroft RA, Chignell AH, Dumonde DC. Cytokines in human intraocular inflammation. Curr Eye Res 1992;11(Suppl.):187–191.
   Google Scholar
• Ellis BA, Patel SY, Stanford MR, Zaman AG, Graham EM, Dumonde DC, Wallace GR. Tumour necrosis factor production by lipopolysac-charide-stimulated peripheral blood mononuclear cells from patients with retinal vasculitis. Reg Immunol 1994;6:27–30.
   Google Scholar
• Verity DH, Holland-Gladwish J, Kanawati C, Ayesh I, Adas F, Zakari H, Stanford M, Wallace G. TNF production by peripheral blood monocytes in Arabic patients with Behçet's disease from Israel and Jordan. Rev Rheumatol 1996;63 (7–8):529 A 03.
   Google Scholar